Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenC-TT and Hib-MenC-TT vaccines in toddlers
NCT00135564Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2003
- Primary completion
- Jul 2003
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of meningococcal group c polysaccharide-tetanus toxoid conjugate vaccine, Hib-MenC-TT in meningococcal disease, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jan 2003; status: completed.
02
Drugs
meningococcal group c polysaccharide-tetanus toxoid conjugate vaccineHib-MenC-TT
03
Conditions
meningococcal diseaseHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00135564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135564.